Atlas Trials

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Clinical trial NCT01642602 · COMPLETED

Trial details

NCT number
NCT01642602
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2012-07-01
Primary completion
2014-01-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.